Last reviewed · How we verify
Modulation of FiO2
At a glance
| Generic name | Modulation of FiO2 |
|---|---|
| Sponsor | Amsterdam UMC, location VUmc |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Nasal Airflow to Modulate Dyspnea in Tracheostomized Patients (NA)
- Association Between Local Cerebral Oxygenation Monitoring and Postoperative Stroke in Carotid Endarterectomy (NA)
- CPAP Therapy Through a Helmet or a Full Face Mask in Patients With Acute Hypoxemic Respiratory Failure: Cross-over Study (NA)
- Accelerated Hypofractionated Intensity - Modulated Radiotherapy After Hyperbaric Oxygenation for Recurrent High Grade Glioma. (NA)
- Liberal Oxygenation Versus Conservative Oxygenation in ARDS (PHASE3)
- The Effect of FiO2 on PaO2/FiO2 Ratio (NA)
- Long Term Outcome on Brain and Lung of Different Oxygen Strategies in ARDS Patients (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Modulation of FiO2 CI brief — competitive landscape report
- Modulation of FiO2 updates RSS · CI watch RSS
- Amsterdam UMC, location VUmc portfolio CI